12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/30/22 18:20
8/22/22
ATNXHealthDrugPharmaceutical PreparationsWu JinnNYDP.d40.42210102485D
8/19/22 16:25
8/19/22
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d90.454902004,504D
11/22/21 16:13
11/22/21
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d61.840304,226D
11/18/21 16:34
11/18/21
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d61.870304,223D
11/18/21 16:29
11/17/21
ATNXHealthDrugPharmaceutical PreparationsKanfer JordanNYDP.d102.020510710D
11/17/21 16:20
11/16/21
ATNXHealthDrugPharmaceutical PreparationsKwan RudolfNYOEVP,ChieP.d82.05042174D
11/17/21 16:16
11/17/21
ATNXHealthDrugPharmaceutical PreparationsWu JinnNYDP.d612.030307433D
11/16/21 16:16
11/16/21
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d62.060304,220D
11/15/21 16:24
11/15/21
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d112.120504,217D
11/12/21 16:41
11/12/21
ATNXHealthDrugPharmaceutical PreparationsLau Johnson Yiu NamNYDOCEO,CBP.d212.0701004,212D
10/13/21 16:37
10/1/21
ATNXHealthDrugPharmaceutical PreparationsWu JinnNYDP.d272.670102413D
9/14/21 17:05
9/14/21
ATNXHealthDrugPharmaceutical PreparationsWu JinnNYDP.d1613.2205014403D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact